Short-term oral administration of ginseng extract induces type-1 cytokine production

Immunopharmacology and Immunotoxicology

Volumn 28, Issue 2, 2006, Pages 227-240

  Liou, Chian Jiun ^a   Huang, Wen Chung ^b   Tseng, Jerming ^c,d  

^a Kang Ning Junior College of Medical Care and Management   (Taiwan)

^b CHANG GUNG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^c CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^d NONE   (Taiwan)

Author keywords

Cytokines; Ginseng; Immunoglobulin

Indexed keywords

CONCANAVALIN A; GAMMA INTERFERON; GINSENG EXTRACT; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 4; LIPOPOLYSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOKINE PRODUCTION; IMMUNOGLOBULIN BLOOD LEVEL; MALE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE SUBPOPULATION;

ADMINISTRATION, ORAL; ANIMALS; ANTIBODY FORMATION; ANTIGENS, CD; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; IMMUNOLOGIC FACTORS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MALE; MICE; MICE, INBRED BALB C; PANAX; SPLEEN; TH1 CELLS; TH2 CELLS;

PANAX GINSENG;

EID: 33746830413     PISSN: 08923973     EISSN: 15322513     Source Type: Journal    
DOI: 10.1080/08923970600816681     Document Type: Article

References (20)

1. Ernst, E. The risk-benefit profile of commonly used herbal therapies: ginkgo, St. John's wort, ginseng, echinacea, saw palmetto, and kava. Ann. Intern. Med. 2002, 136(1), 42-53.
2. Vogler, B.K.; Pittler, M.H.; Ernst, E. The efficacy of ginseng. A systematic review of randomized clinical trials. Eur. J. Clin. Pharmacol. 1999, 55(8), 567-575.
3. Kim, J.Y.; Germolec D.R.; Luster, M.I. Panax ginseng as a potential immunomodulator; studies in mice. Immunopharmacol. Immunotoxicol. 1990, 12(2), 257-276.
4. Yun, Y.S.; Lee Y.S.; Jo S.K.; Jung, I.S. Inhibition of autochthonous tumor by ethanol insoluble fraction from Panax ginseng as an immunomodulator. Planta Med. 1993, 59(6), 521-524.
5. Lee, Y.S.; Chung I.S.; Lee I.R.; Kim K.H.; Hong, W.S.; Yun Y.S. Activation of multiple effector pathways of immune system by the antineoplastic immunostimulator acidic polysaccharide ginsan isolated from Panax ginseng. Anticancer Res. 1997, 17(1A), 323-331.
6. Kim K.H.; Lee, Y.S.; Jung, I.S.; Park, S.Y.; Chung, H.Y.; Lee, I.R.; Yun, Y.S. Acidic polysaccharide from panax ginseng, ginsan, induces Th1 cell and macrophage cytokines and generates LAK cells in synergy with rIL-2. Planta Med. 1998, 64(2), 110-115.
7. Jie, Y.H.; Cammisuli, S.; Baggiolini, M. Immunodulatory effects of panax ginseng C.A. Meyer in the mouse. Agent Action 1984, 15(3/4), 386-391.
8. Scaglione, F.; Cattaneo, G.; Alessandria, M.; Cogo, R. Efficacy and safety of the standardized ginseng extract G115 for potentiating vaccination against the influenza syndrome and protection against the common cold. Drug Exp. Clin. Res. 1996, 22(2): 65-72.
9. Song, Z.J.; Johansen, H.K.; Faber, V.; Høiby, N. Ginseng treatment enhances bacterial clearance and decreases lung pathology in athymic rats with chronic P. aeruginosa pneumonia. APMIS 1997, 105(6): 438-444.
10. Kim, Y.W.; Song, D.K.; Kim, W.H.; Lee, K.M.; Wie, M.B.; Kim, Y.H.; Kee, S.H.; Cho, M.K. Long-term oral administration of ginseng extract decreases serum gamma-globulin and IgG1 isotype in mice. J. Ethnopharmacol. 1997, 58(1), 55-58.
11. Liou, C.J.; Li, M.L.; Tseng, J. Intraperitoneal injection of ginseng extract enhances both immunoglobulin and cytokine production in mice. Am. J. Chin. Med. 2004, 32(1), 1-14.
12. Snapper, C.M.; Paul, W.E. Interferon-γ and B cell stimulatory factor-1 recipicolly regulate Ig isotype production. Science 1987, 236(4804), 944-947.
13. Trinchieri, G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Ann. Rev. Immunol. 1995, 13:251-276.
14. Song, Z.; Johansen, H.K.; Fabber, V.; Moser, C.; Kharazmi, A.; Rygaard, J.; Høiby, N. Ginseng treatment reduces bacterial load and lung pathology in chronic pseudomonas aeruginosa pneumonia in rats. Antimicrobiol. Agent. Chemother. 1997, 41(5): 961-964.
15. Fiorentino, D.F.; Bond, M.W.; Mosmann, T.R. Two types of mouse helper T cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J. Exp. Med. 1989, 170(6), 2081-2095.
16. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997, 389(6652), 737-742.
17. Moore, K.W.; de Waal Malefyt, R.; Coffman, R.L.; O'Garra, A. Interleukin-10 and the interleukin-10 receptor. Ann. Rev. Immunol. 2001, 19, 683-765.
18. Taga, K.; Tosato, G. IL-10 inhibits human T cell proliferatiob and IL-2 production. J. Immunol. 1992, 148(4), 1143-1148.
19. Rousset, F.; Garcia, E.; Defrance, T.; Peronne, C.; Vezzio, N.; Hsu, D-H.; Kastelein, R.; Moore, K.W.; Banchereau, J. Interleukin 10 is a potent growth and differentiation factor for activated human B lymphocytes. Proc. Natl. Acad. Sci. USA 1992, 89(5), 1890-1893.
20. Pecanha, L.M.; Snapper, C.M.; Lees, A.; Yamaguchi, H.; Mond, J.J. IL-10 inhibits T cell-independent but not T cell-dependent responses in vitro. J. Immunol. 1993, 150(8), 3215-3223.